Breast Cancer Index reposted this
Most women with hormone receptor-positive, early-stage breast cancer begin taking anti-estrogen therapy, also called hormone or endocrine therapy, to lower the risk of recurrence after they finish their initial treatment and begin navigating survivorship. Tune in to the latest episode of Real Pink to hear Nurse Practitioner, Adriana Olivo, discuss how patients and providers can balance fear of recurrence against the potential side effects of these treatments and how genomic testing tools can help guide treatment decisions. https://apple.co/2LMAcsi Thanks Hologic, Inc. for supporting the Real Pink Podcast.
Social Media Content Creator
1moUnfortunately we are seeing that even those medication lower the risk very minimally. So many woman are being rediagnosed even after taking 5-10 years of tamoxifens etc.